Previous 10 | Next 10 |
MURRAY, Utah, Aug. 31, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, announced an agreement to be the exclusive provider of r...
MURRAY, Utah, Aug. 25, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), announced today a 10-year partnership with St. Clair Health to serve as its primary provider of end-to-end revenue cycle management (RCM) services. St. Clair Health is a nationally rec...
R1 RCM Inc. (RCM) Q2 2022 Earnings Conference Call August 3, 2022 8:00 AM ET Company Participants Atif Rahim - Head, Investor Relations Joseph Flanagan - President & Chief Executive Officer Lee Rivas - President Rachel Wilson - Executive Vice President, C...
R1 RCM press release ( NASDAQ: RCM ): Q2 GAAP EPS of -$0.07 misses by $0.11 . Revenue of $391.9M (+10.9% Y/Y) in-line. 2022 Outlook For 2022, R1 expects to generate: Revenue of between $1,850 million and $1,870 million GAAP operating income of $...
MURRAY, Utah, Aug. 03, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended June 30, 2022. ...
R1 RCM ( NASDAQ: RCM ) is scheduled to announce Q2 earnings results on Wednesday, August 3rd, before market open. The consensus EPS Estimate is $0.08 (+103.7% Y/Y) and the consensus Revenue Estimate is $391.58M (+10.8% Y/Y). Over the last 1 year, RCM has beaten EPS e...
ABC , ALE , OTCPK:AMKBY , AMRN , AROC , ATHM , AVA , AY , BCO , BDC , BERY , BFLY , BGCP , BIP , OTCPK:BMWYY , BRSP , BRY , BWA , CARS , CCRD , CDW , CLDT , CLH , CRL , CRTO , CSTE , ...
MURRAY, Utah, July 20, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ...
R1 RCM’s intra-quarter guidance update was net positive, with a downward revision for Q2 2022 offset by a stronger 2022/2023 outlook. Cloudmed equips RCM with a complete one-stop offering, further accelerating its growth outlook over the long run. With RCM well on its way t...
Gainers: NexImmune ( NEXI ) +34% . Allogene Therapeutics ALLO +12% . SOPHiA GENETICS ( SOPH ) +12% . Verona Pharma ( VRNA ) +8% . R1 RCM ( RCM ) +7% . Losers: Codexis ( CDXS ) -43% . 10x Genomics ( TXG ...
News, Short Squeeze, Breakout and More Instantly...
MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended ...
2024-07-09 09:00:05 ET George Hill from Deutsche Bank issued a price target of $16.00 for RCM on 2024-07-09 07:36:00. The adjusted price target was set to $16.00. At the time of the announcement, RCM was trading at $12.66. The overall price target consensus is at $19.00 ...
2024-07-08 09:30:06 ET Morgan Stanley analyst issues OVERWEIGHT recommendation for RCM on July 8, 2024 07:50AM ET. The previous analyst recommendation was Overweight. RCM was trading at $10.95 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...